The U.S. and U.K. have reached a landmark agreement in principle on pharmaceutical pricing, an outcome senior Trump administration officials say corrects decades of unfair trade practices that left American patients footing the world’s drug bill.
Announced jointly by the Office of the U.S. Trade Representative, the Commerce Department, and Health and Human Services, the deal is a pillar of the historic U.S.-U.K. Economic Prosperity Deal struck by President Donald Trump and British Prime Minister Keir Starmer.
The agreement aims to rebalance pharmaceutical trade, strengthen supply chains, and expand U.K. investment in U.S. drug development.
Read more at Newsmax© 2025 Newsmax. All rights reserved.